Cannabis Rescheduling Explained: Schedule III Status

Cannabis rescheduling is the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act. In May 2024 the Drug Enforcement Administration published a proposed rule to make that move, after the Department of Health and Human Services recommended it in 2023. Rescheduling is not legalization. Federal prohibition of recreational cannabis would remain, state-licensed programs would keep running under state law, and no final DEA rule has been issued. Until that rule lands, cannabis stays Schedule I for federal purposes.

Cannabis Rescheduling Update: Everything You Need to Know

Terms worth knowing before the details

• Schedule I: drugs with no currently accepted medical use and a high potential for abuse, such as heroin, LSD, and cannabis.
• Schedule III: drugs with accepted medical use and moderate to low physical dependence risk, such as ketamine and testosterone.
• Rescheduling: moving a controlled substance from one schedule to another.
• Descheduling: removing a drug from the Controlled Substances Act entirely.
• Legalization: passing federal law that permits possession and sale.

What Schedule III would change

Schedule III carries real consequences for businesses, researchers, and patients, even though it stops short of full legal status.

cannabis rescheduling impact on legality

• Tax treatment: Section 280E of the tax code blocks deductions for businesses that traffic in Schedule I and II substances. Schedule III would lift that restriction for state-licensed operators.
• Research: Schedule III registration rules are less strict, so clinical studies are easier to run and easier to fund.
• Criminal exposure: penalties for Schedule III offenses are lower than the penalties attached to Schedule I offenses.
• Regulatory oversight: FDA and DEA manufacturing standards would apply to cannabis products alongside state cannabis rules.

What rescheduling would not do

• It would not make recreational cannabis legal nationwide.
• It would not erase state licensing rules, testing rules, or possession limits.
• It would not turn a state medical card into a federal prescription.
• It would not fix banking access for cannabis businesses on its own, since that requires separate legislation.
• It would not rewrite hemp rules for delta-8, delta-10, or low-dose delta-9 products.

The rescheduling process, step by step

1. HHS reviews the science. FDA and NIDA weigh medical usefulness and abuse potential, then HHS sends a scheduling recommendation to DEA, which it delivered in August 2023.
2. DEA drafts a proposed rule, published as a notice of proposed rulemaking in the Federal Register on May 21, 2024.
3. The public files comments during the open window, which closed on July 22, 2024 with roughly 43,000 comments on record.
4. DEA convenes an administrative hearing, where an administrative law judge takes evidence from supporters, opponents, and agency witnesses. Hearings opened on January 21, 2025.
5. The judge submits a recommended decision, which informs the agency but does not bind it.
6. The DEA Administrator signs a final rule, adopting, modifying, or rejecting the recommendation.
7. Federal courts review any challenges, which can stretch the timeline past the agency stage.

What it means for THC products and online orders

Two legal tracks matter here. Cannabis flower and high-THC concentrates sit inside state medical or adult-use programs and the Controlled Substances Act. Hemp-derived items such as delta-8 gummies or low-dose delta-9 seltzers sit inside the 2018 Farm Bill framework instead, and a change to marijuana's schedule does not change those rules by itself. State legislatures have moved in both directions on hemp cannabinoids, so the rules differ from one state to the next.

Cannabis Rescheduling vs Legalization: What Changes for Buyers

If Schedule III takes effect, shoppers would notice the effects over time. Cultivators and retailers would pay less in federal tax, testing capacity and research funding would grow, and the FDA would take a more formal role in what can be sold and how labels read. Product menus and prices at state-licensed shops could shift. None of that happens when a rule is proposed. Only a published final rule changes federal law.

latest cannabis rescheduling news

What to watch next

• The DEA hearing schedule and any recommended decision from the administrative law judge.
• A final rule in the Federal Register, the only document that actually reschedules cannabis.
• Federal appeals that could pause or undo the change.
• Congress, where banking, hemp cannabinoid, and legalization bills move on separate tracks.

This guide is general information, not legal advice. Cannabis rules vary by state and change often. Check your state regulations before you buy or sell.